Home
Indication Area
NRT
Pharma
Partners
Team
Newsroom
CONTACT US
Home
Indication Area
NRT
Pharma
Partners
Team
Newsroom
contact us
Home
Indication Area
NRT
Pharma
Partners
Team
Newsroom
Home
Indication Area
NRT
Pharma
Partners
Team
Newsroom
CONTACT US
Have a Project in Mind? Say Hi!
+1 800 123 456 789
+1 800 123 654 987
Mon - Sun: 10am - 10pm
27 Division St, New York,
NY 10002, USA
grido@mail.com
Home
Blog Listing
Blog Listing
December 13, 2022
PharmaShots
BY
admin
0 COMMENTS
Brian Quigley, CEO at Qnovia Shares Insights on Respira Technologies Rebranded as Qnovia
December 16, 2022
Flipboard
BY
admin
0 COMMENTS
Qnovia Aiming For 2025 Approval Of Heatless Nicotine Nebulizer
December 16, 2022
MediaPost
BY
admin
0 COMMENTS
Qnovia Aiming For 2025 Approval Of Heatless Nicotine Nebulizer
December 16, 2022
Richmond Biz Journals
BY
admin
0 COMMENTS
Qnovia aims to bring smoking cessation medical device to market in 2025
December 19, 2022
Fierce Pharma
BY
admin
0 COMMENTS
2023 forecast: The biopharma name changing craze and the shifting sands of corporate branding
December 27, 2022
PharmaShots
BY
admin
0 COMMENTS
Brian Quigley, CEO at Qnovia Shares his Views on Raising Series A Funding
January 8, 2023
Barron's
BY
admin
0 COMMENTS
It’s Pharma Time: Why Merck and Lilly Are Buys, but Not Pfizer.
1
2
3
4
5
6
#side-panel.side-panel {width: 500px;}#side-panel.side-panel .side-panel_sidebar {padding: 70px 0px 50px 60px;background-color: #FFFFFF;}
Qnovia